AVADEL PHARMACEUTICALS PLC shareholders Q3 2023

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 102 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 21,680$223,3040.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 11,434$117,7710.00%
NewEdge Advisors, LLC 1,300$13,3900.00%
Squarepoint Ops LLC 14,582$150,1950.00%
CITIGROUP INC 2,630$27,0890.00%
SALEM INVESTMENT COUNSELORS INC 450$4,6350.00%
OSAIC HOLDINGS, INC. 20,597$212,1450.00%
Parallel Advisors, LLC 42$4330.00%
Walleye Capital LLC 5,900$60,7700.00%
Walleye Capital LLC 8,500$87,5500.00%
RHUMBLINE ADVISERS 1,256$12,9360.00%
Lindbrook Capital, LLC 98$1,0090.00%
BNP PARIBAS FINANCIAL MARKETS 1,159$11,9380.00%
Banque Cantonale Vaudoise 1,000$100.00%
Blue Zone Wealth Advisors, LLC 15,000$1550.00%
GEODE CAPITAL MANAGEMENT, LLC 94,405$972,3710.00%
MILLENNIUM MANAGEMENT LLC 54,726$563,6780.00%
BlackRock Inc. 78,485$808,3950.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 2,250$23,1750.00%
External links

This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q3 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.